Assessing the Role of Patient Race in Disparity of 90-Day Brain Tumor Resection Outcomes.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32360924.
- Also identified by DOI 10.1016/j.wneu.2020.04.098.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study assesses the influence of race on patient outcomes in a brain tumor surgery population. Coarsened exact matching was used to retrospectively analyze 1700 supratentorial brain tumor procedures over a 6-year period (June 7, 2013 to April 29, 2019) at a single, multihospital academic medical center. Outcome measures included readmission, mortality, emergency room visits, and reoperation. McNemar test (mid-P) showed no significant difference in 90-day mortality between the 2 races (P = 0.3018). However, there was a significant difference in 90-day readmissions between the 2 races (P = 0.0237). There was no significant difference in 90-day emergency room visits (P = 0.0579), 90-day return to surgery after index admission (P = 0.6015), or return to surgery within 90 days (P = 0.6776) between the 2 races. There was also no significant difference in return to surgery for the duration of the follow-up period (P = 0.8728). This study suggests that race alone does not result in disparate outcomes; however, there was an associated difference in 90-day postsurgical readmissions. Despite coarsened exact matching, persistent differences in median household income may play a role in the disparate outcome noted.
Medical subject headings
- Brain Neoplasms
- Healthcare Disparities
- Neurosurgical Procedures
- Racial Groups
- Supratentorial Neoplasms